Arash Mostaghimi
Dermatology — Brigham and Women's Hospital, United States
Arash Mostaghimi
LeadR Profile
Dermatology
Subspecialties: Public Health - Pharmacy - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2010 - 2026
Number : 479
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Clinical Outcomes in a Longitudinal Virtual Dermatology Care Model for Eczema and Psoriasis. eczema, psoriasis, dermatology | Dermatol Pract Concept | 2026 | 0 |
| Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2. safety, alopecia areata, therapeutics, alopecia | Dermatol Ther (Heidelb) | 2026 | 0 |
| Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults. alopecia areata, skin diseases, surveys and questionnaires, research, therapeutics, alopecia | JAMA Dermatol | 2026 | 1 |
| Oropharyngeal ulcers in Yao syndrome with multisystem involvement. ulcer | Lancet Top journal | 2026 | 0 |
| Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials. quality of life, achievement, safety, alopecia areata, skin diseases, drug-related side effects and adverse reactions, adolescent, therapeutics, alopecia | JAMA Dermatol | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) NCT07533006 — safety, alopecia areata, pharmaceutical preparations, proof of concept study, alopecia | Phase 2 | Recruiting | 2026 |
| A Study of LY4005130 in Adult Participants With Non Segmental Vitiligo NCT07533019 — safety, pharmaceutical preparations, vitiligo, proof of concept study | Phase 2 | Recruiting | 2026 |
| A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata NCT06012240 — safety, alopecia areata, pharmaceutical preparations, tablets, adolescent, therapeutics, alopecia | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map